jump to content jump to footer

Categories: Clinical Trials

Research poster presentation on standardized tumor response assessments using mint Lesion at the NCCN Annual Conference 2026
Presentation of a research poster by Memorial Sloan Kettering Cancer Center on the use of mint Lesion for structured tumor response assessments and clinical research workflows.
NCCN 2026: Memorial Sloan Kettering Cancer Center Presents Research on Structured Tumor Response Assessments with mint Lesion
Big congratulations to Steven Philemond and Alison Chiaramonte of Memorial Sloan Kettering Cancer Center for presenting their research poster “Use of…
Read more
Radiologist analyzing whole-body MRI scans of prostate cancer bone metastases using AI-assisted tumor load quantification in mint Lesion
How mint Lesion supports radiologists in AI-assisted tumor load quantification for bone metastases in prostate cancer with structured analysis, objective metrics, and longitudinal therapy assessment.
AI-Supported Tumor Load Quantification for Bone Metastasis in Prostate Cancer
To assess treatment response in patients with advanced prostate cancer, radiologists rely on advanced medical imaging. Conventional modalities, such…
Read more
Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion
Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…
Read more
scroll-top